Company Filing History:
Years Active: 1983-1984
Title: Innovator Donald D Smith: Advancements in Feline Health
Introduction
Donald D Smith, located in Independence, MO, is a notable inventor with a significant contribution to veterinary medicine, particularly in the health of cats. He holds two patents that specifically address the prevention of Toxoplasma oocyst shedding in cats, showcasing his innovative approach towards animal health and welfare.
Latest Patents
1. **Method of Immunizing Cats Against Shedding of Toxoplasma Oocysts**
This patent describes a method wherein cats are initially given a primary Toxoplasma infection through tissue cysts. Following this, a chemoprophylactic treatment is administered to suppress oocyst shedding. The treatment involves the use of monensin in the daily ration of the cats, ensuring they achieve immunity without the initial shedding of oocysts. Other potential treating agents mentioned include salinomycin or a combination of sulfadiazine and pyrimethamine.
2. **Method for Preventing Cats from Shedding Toxoplasma Oocysts After Infection**
This patent outlines a method aimed at preventing or significantly minimizing the shedding of Toxoplasma oocysts by infected cats. The method involves administering effective amounts of monensin or salinomycin, preferably through the cat's food or via a slow-release dosage form, shortly after infection, for a duration that typically lasts at least two weeks. The aim is to reduce the contamination of soils in areas inhabited by humans, thus enhancing public health safety.
Career Highlights
Donald D Smith is associated with the Kansas University Endowment Association, where he has likely collaborated on various research initiatives aimed at improving veterinary practices. His work in immunization methods demonstrates a commitment to advancing animal health, making significant strides in how veterinarians can manage feline health issues associated with Toxoplasma.
Collaborations
During his career, Smith has worked alongside Jacob K Frenkel, contributing to research that has yielded vital insights into the management of Toxoplasma infections in cats. Their collaboration signifies the importance of teamwork in driving innovation in the research community.
Conclusion
In summary, Donald D Smith’s pioneering work in the development of methods to prevent Toxoplasma oocyst shedding in cats represents an important innovation in the field of veterinary medicine. His contributions are not only beneficial for feline health but also play a crucial role in safeguarding public health from potential zoonotic diseases. As he continues his work at the Kansas University Endowment Association, further contributions to the field can be anticipated.